4d Pharma Plc Accounts Payable

4d Pharma Plc (LBPS) currently reports a accounts payable of $1.7M as of December 2021. That compares with $3.3M in the prior-year period — down 49.2% year over year. Use the charts on this page to explore 4d Pharma Plc's accounts payable history and peer comparisons.

4d Pharma Plc's accounts payable decreased from $3.3M to $1.7M — a 49.2% year-over-year decrease (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

4d Pharma Plc reported $1.7M in accounts payable as of December 2021. That compares with $3.3M in the prior-year period — down 49.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 4d Pharma Plc, and consider following LBPS for alerts when major investors trade the stock.

4d Pharma Plc is classified in the Healthcare sector. On accounts payable, it currently shows $1.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LBPS with unrelated industries.